Anaerovibrio lipolyticus Details: NCBI 82374, gram-negative or unknown [species]

| Anaerovibrio lipolytica| Anaerovibrio lipolyticus| Anaerovibrio lipolyticus corrig. Hungate 1966| ATCC 33276| CIP 105407| DSM 3074| VPI 7553

  1. Lipid Metabolism: Anaerovibrio lipolyticus has been identified as a bacterium capable of hydrolyzing lipids. Lipid metabolism by gut bacteria can contribute to the breakdown of dietary fats and the production of various metabolites.

  2. Anaerobic Fermentation: Anaerovibrio bacteria are anaerobic fermenters, and they are involved in the fermentation of organic compounds in the absence of oxygen. This fermentation process can result in the production of short-chain fatty acids (SCFAs) and other metabolic byproducts.

  3. Gut Microbial Community: Anaerovibrio lipolyticus is part of the overall gut microbial community. The composition and balance of the gut microbiota play a crucial role in various aspects of human health, including digestion, nutrient absorption, and immune system regulation.

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
  Statistics   NCBI   Data Punk   End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Anaerovibrio lipolyticus

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 0.35 6 1360 0 1700 558.3 410 582.3 6 1360 10 %ile 80 %ile
biomesight 84.2 0 810 50 1409 0 11288 1265.9 300 5113.5 0 1540 8 %ile 91 %ile
thryve 1.44 7 160 0 103 28.3 14 38.3 7 160 0 %ile 100 %ile

External Reference Ranges for Anaerovibrio lipolyticus

Anaerovibrio lipolyticus (NCBI 82374) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Statistic by Lab Source for Anaerovibrio lipolyticus
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
BiomeSight 89.909 %   0.119 %  0.457 % 2664.0 2963
BiomeSightRdp 19.355 %   0.307 %  0.602 % 6.0 31
custom 4.918 %   0.087 %  0.07 % 3.0 61
Medivere 14.286 %   0.001 %  % 1.0 7
Thryve 1.727 %   0.021 %  0.086 % 24.0 1390

To see medical conditions associated you may be logged in

And display level must be raised above public.

I would like to know what can change the quality that I have

Data Contradictions — Limits of Certainity

To get the list of studies, you must be logged in and raise your display level.

🧙? Search Hints:
General Substance Specific Substance Effect
Diet Style Olive Oil 1 Studies recorded. The consensus is Decreases📓, Click for details.
flavonoids, polyphenols etc chestnut tannins 1 Studies recorded. The consensus is Increases📓, Click for details.
flavonoids, polyphenols etc quebracho 1 Studies recorded. The consensus is Increases📓, Click for details.
Food (excluding seasonings) fish oil 1 Studies recorded. The consensus is Increases📓, Click for details.
Herb or Spice berberine 1 Studies recorded. The consensus is Increases📓, Click for details.
Herb or Spice fucoidan 1 Studies recorded. The consensus is Increases👶, Click for details.
Herb or Spice ginko 1 Studies recorded. The consensus is Increases👶, Click for details.
Herb or Spice Perilla frutescens(shiso) 1 Studies recorded. The consensus is Increases📓, Click for details.
Miscellaneous, food additives, and other odd items humic substances 1 Studies recorded. The consensus is Decreases📓, Click for details.
Prebiotics and similar galacto-oligosaccharides (prebiotic) 1 Studies recorded. The consensus is Increases📓, Click for details.
Prescription - Other helminth infection (prescription) 1 Studies recorded. The consensus is Increases📓, Click for details.
Probiotics bifidobacterium bifidum (probiotics) 1 Studies recorded. The consensus is Decreases📓, Click for details.
Probiotics saccharomyces boulardii (probiotics) 1 Studies recorded. The consensus is Increases📓, Click for details.

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.